Effects of MPEP on expression of food‐, MDMA‐ or amphetamine‐conditioned place preference in rats
- 1 September 2005
- journal article
- Published by Wiley in Addiction Biology
- Vol. 10 (3), 243-249
- https://doi.org/10.1080/13556210500223272
Abstract
Recent studies have revealed the effectiveness of 2-methyl-6-(phenylethynyl)pyridine (MPEP), a highly selective antagonist of metabotropic glutamate receptors subtype 5 (mGluR5), in conditioned drug reward. In a previous study we showed that MPEP blocks expression of context-conditioned morphine- but not cocaine reward in the rat. The present study now examines the effectiveness of MPEP in the expression of context-conditioned food, MDMA (‘ecstasy?) or amphetamine reward. Therefore, three groups of rats were conditioned either to food, MDMA or amphetamine in the conditioned place preference (CPP) paradigm. After conditioning, CPP expression and locomotion were determined simultaneously in the presence and absence of the respective reward (i.e. food or drug), or after application of 50?mg/kg MPEP (the dose that was most effective in reducing morphine CPP expression in our previous study). As a result, MPEP reduced locomotion in all groups. Furthermore, only expression of amphetamine CPP was inhibited by MPEP, while expression of food and MDMA CPP was not affected, suggesting that the MPEP-induced inhibition of amphetamine CPP expression was not causally linked to the reduction of locomotion. Overall, we conclude that MPEP reduces expression of context-conditioned amphetamine but not MDMA or food reward.Keywords
This publication has 25 references indexed in Scilit:
- Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed ratsNeuroscience Letters, 2005
- Glutamate systems in cocaine addictionCurrent Opinion in Pharmacology, 2004
- mGluR5 Antagonist MPEP Reduces Ethanol-Seeking and Relapse BehaviorNeuropsychopharmacology, 2003
- Glutamatergic mechanisms in addictionMolecular Psychiatry, 2003
- Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB‐1893 and MPEPBritish Journal of Pharmacology, 2003
- Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonistNeuropharmacology, 2002
- [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo CharacterizationJournal of Pharmacology and Experimental Therapeutics, 2002
- Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine (‘Ecstasy’) and 3,4-methylenedioxy-ethylamphetamine (‘Eve’) measured by conditioned place preference in ratsNeuroscience Letters, 2002
- Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant miceNature Neuroscience, 2001
- Selective mGluR5 antagonists MPEP and SIB‐1893 decrease NMDA or glutamate‐mediated neuronal toxicity through actions that reflect NMDA receptor antagonismBritish Journal of Pharmacology, 2000